← Leaderboards
Connie L Celum
University Of Washington
$55,222,861
Attributed
$63,491,948
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$91,480,017 · 15
By mechanism
P30$32,919,659 · 5
R01$30,906,472 · 7
U01$22,080,954 · 2
RC4$5,572,932 · 1
Top collaborators
- Anne Frey Luetkemeyer7 shared
- Linda-Gail Bekker5 shared
- Sinead Delany-Moretlwe5 shared
Most similar at University Of Washington
Same institution · by research overlap
- Albert R La Spada$44,944,106
- Stuart Shankland$30,345,727
- Jay W Heinecke$34,087,651
- Beti Thompson$30,192,370
- Anna Wald$34,443,936
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BasePreventionProgramsPersonsEpidemicAids PreventionHiv InfectionsInfectionDesignResearch PersonnelFundingResourcesUniversitiesInnovationServicesAcquired Immunodeficiency SyndromeSuccessBehavioralUptakePre-Exposure ProphylaxisFuturePrevention StrategySexually Transmitted DiseasesCouples
Grant awards (74)
University of Washington/Fred Hutch Center for AIDS Research$3,565,036
P30 · FY2025 · AI · contact PI
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratios$1,493,206
R01 · FY2025 · AI
A: Administrative$533,681
P30 · FY2025 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$3,581,608
P30 · FY2024 · AI · contact PI
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratios$1,628,180
R01 · FY2024 · AI
A: Administrative$1,125,762
P30 · FY2024 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$536,547
P30 · FY2024 · AI · contact PI
A: Administrative$536,547
P30 · FY2024 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$224,721
P30 · FY2024 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$214,866
P30 · FY2024 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$178,593
P30 · FY2024 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$3,946,565
P30 · FY2023 · AI · contact PI
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men$1,412,385
R01 · FY2023 · AI
A: Administrative$551,651
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$551,651
P30 · FY2023 · AI · contact PI
A: Administrative$463,966
P30 · FY2023 · AI · contact PI
A: Administrative$298,465
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$298,465
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$227,790
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$227,551
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$210,439
P30 · FY2023 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$4,901,036
P30 · FY2022 · AI · contact PI
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men$2,586,659
R01 · FY2022 · AI
University of Washington/Fred Hutch Center for AIDS Research$4,415,314
P30 · FY2021 · AI · contact PI
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men$1,431,796
R01 · FY2021 · AI
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda$653,273
R01 · FY2021 · MH · contact PI
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design$584,219
R01 · FY2021 · MH · contact PI
University of Washington/Fred Hutch Center for AIDS Research$264,750
P30 · FY2021 · AI · contact PI
University of Washington/Fred Hutch Center for AIDS Research$4,643,137
P30 · FY2020 · AI · contact PI
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men$1,464,310
R01 · FY2020 · AI
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda$655,190
R01 · FY2020 · MH · contact PI
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design$583,356
R01 · FY2020 · MH · contact PI
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men$1,418,675
R01 · FY2019 · AI
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda$663,527
R01 · FY2019 · MH · contact PI
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design$575,064
R01 · FY2019 · MH · contact PI
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda$681,037
R01 · FY2018 · MH · contact PI
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design$619,670
R01 · FY2018 · MH · contact PI
Design and delivery of combination HIV prevention in young South African women$395,388
R01 · FY2018 · MH
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda$726,087
R01 · FY2017 · MH · contact PI
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design$700,439
R01 · FY2017 · MH · contact PI
Design and delivery of combination HIV prevention in young South African women$693,209
R01 · FY2017 · MH
Design and delivery of combination HIV prevention in young South African women$350,000
R01 · FY2016 · MH
Design and delivery of combination HIV prevention in young South African women$251,618
R01 · FY2016 · MH
Design and delivery of combination HIV prevention in young South African women$350,000
R01 · FY2015 · MH
Interventions to decrease HIV infectiousness in Uganda$513,724
RC4 · FY2013 · AI · contact PI
Interventions to decrease HIV infectiousness in Uganda$1,159,185
RC4 · FY2012 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$756,962
R01 · FY2012 · AI · contact PI
Clinical Research$336,874
P30 · FY2012 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$772,016
R01 · FY2011 · AI · contact PI
Clinical Research$374,892
P30 · FY2011 · AI · contact PI
Interventions to decrease HIV infectiousness in Uganda$3,900,023
RC4 · FY2010 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$844,990
R01 · FY2010 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$511,668
R01 · FY2010 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$499,989
R01 · FY2010 · AI · contact PI
Clinical Research$184,687
P30 · FY2010 · AI · contact PI
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx$924,150
R01 · FY2009 · AI · contact PI
Clinical Research$212,641
P30 · FY2009 · AI · contact PI
Clinical Research$196,045
P30 · FY2008 · AI · contact PI
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons$2,909,511
U01 · FY2007 · AI · contact PI
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons$4,838,673
U01 · FY2006 · AI · contact PI
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons$1,482,575
U01 · FY2006 · AI · contact PI
STDS AND HETEROSEXUAL 'BRIDGING' AMONG MEN WHO HAVE SEX$424,170
U01 · FY2006 · AI · contact PI
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons$4,363,778
U01 · FY2005 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$997,486
U01 · FY2005 · AI
Acylovir to prevent HIV acquisition in HSV-2+persons$1,625,723
R01 · FY2004 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$779,645
U01 · FY2004 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$209,087
U01 · FY2004 · AI
Core-Clinical Research$116,379
P30 · FY2004 · AI
Acylovir to prevent HIV acquisition in HSV-2+persons$2,481,754
R01 · FY2003 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$965,159
U01 · FY2003 · AI
Acylovir to prevent HIV acquisition in HSV-2+persons$2,571,932
R01 · FY2002 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$1,941,480
U01 · FY2002 · AI
STDS AND HETEROSEXUAL 'BRIDGING'AMONG MEN WHO HAVE SEX$1,869,390
U01 · FY2001 · AI
STDS AND HETEROSEXUAL BRIDGING AMONG MEN WHO HAVE SEX$1,300,000
U01 · FY2000 · AI